Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of MSB-CAR001 in Subjects 6 Weeks Post an Anterior Cruciate Ligament Reconstruction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Males or females at least 18 years of age, but not older than 40~2. ACL injury requiring reconstruction~3. Have undergone unilateral ACL reconstruction surgery within six months of injury;~4. Willing and able to undertake a standardized rehabilitation protocol~5. ACL graft used is autograft~6. Willingness to participate in follow-up for 24 months from the time of initial treatment~7. Ability to understand and willingness to sign consent form~Exclusion Criteria:~1. Women who are pregnant or breast feeding or planning to become pregnant during the study~2. Previous allergic reaction to Hyaluronan~3. Systemic or local infection at the screen visit or at the time of the study injection~4. History of any autoimmune disease, such as, systemic lupus erythematosus, Addison's disease, Crohn's disease, or rheumatoid arthritis~5. Treatment with immunosuppression therapy within 6 months prior to screen (visit 1)~6. Acute or chronic infectious disease, including but not limited to human immunodeficiency virus (HIV);~7. Treatment and /or uncompleted follow-up treatment of any investigational therapy within 6 months before the procedure and /or intent to participate in any other investigational drug or cell therapy study during the 24 month follow-up period of this study;~8. Recipient of prior allogeneic stem cell/progenitor cell therapy~9. Undergoing a simultaneous procedure to the opposite knee~10. 20% or greater anti-human leukocyte antigen (HLA) antibody titer and/or has antibody specificities to donor HLA antigens;~11. Known sensitivities to bovine (cow), murine (mouse), chicken products and/or dimethylsulfoxide (DMSO). Previous allergic reaction to Hyaluronan;~12. History or current evidence of alcohol or drug abuse or is a recreational user of illicit drugs or prescription medications~13. History of prior surgery to the study knee joint~14. History of malignancy (excluding basal cell carcinoma that has been successfully excised)~15. Chondral lesions noted at time of surgical reconstruction greater than Grade 1a on any surfaces

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Hyaluronan Alone (Type: ACTIVE_COMPARATOR): Hyaluronan Alone
- MSB-CAR001 (Type: EXPERIMENTAL): Single Dose of MSB-CAR001 Combined With Hyaluronan

Based on this trial design, predict the completion outcome and termination type (if applicable).